Milan, Italy – Exom Group is proud to announce, that we have been awarded the 2020 Healthcare & Pharmaceutical Award for “Most Innovative Clinical Trials Virtualisation CRO 2020”.
As an awardee Exom needed to demonstrate expertise within our field, dedication to customer service and a commitment to promoting excellence. The judging process was driven by merit and centered around an in-depth evaluation of skills and services on offer.
“We are very honored by receiving the award”, says Dr. Visani, CEO & Founder of Exom Group. Further he continued: “This shows, that Exom’s approach to virtual clinical trials is what is currently needed within the industry. By offering an integrated approach, consisting of human expertise, state-of-the-art software solutions, remote patient’s monitoring and advanced analytics, we enable sponsors, patients and site staff, to collaborate in an entirely new way.”
“What was unthinkable in the past now becomes the new way of conducting clinical trials”, added Patrick McManus, Chief Development Officer at Exom Group. “Since 2014 we have been successfully implementing innovative digital solutions in many clinical trials, therefore we are the ideal partner CRO for the virtualization of clinical research, particularly in turbulent times like the current ones.”
For more information, please feel free to contact us.